Director GraphAware Solutions EMEA (UK based)
As the Director of GraphAware Solutions EMEA, you will drive growth by leading strategic sales initiatives and partnerships within the national security and intelligence sectors across Europe.
Apollo After School is a leading national provider of research-based extended-day programs for Pre-Kβ8th graders.
At Apollo After School, we create a nurturing, inclusive space where kids thrive after the bell rings. Through diverse, hands-on activities, we spark curiosity, foster lifelong learning, unleash creative potential, and nurture the self-confidence that empowers them to shine.
Our project-based curriculum turns students into confident problem-solvers. By guiding them to ask bold questions, leverage their unique strengths, and acquire fresh skills, we equip them with essential tools: goal-setting mastery, deep empathy, meaningful connections, and wise decision-making that lasts a lifetime.
We are seeking a dynamic and results-driven National Director of Business Development to join our growing team for a full-time position. In this role, you will drive business development by partnering with schools and districts across the United States to expand Apollo After School's extended day program. The ideal candidate is a passionate advocate for education with a proven track record in business development, particularly in the educational sector. This position is remote with significant travel required to build relationships and establish partnerships with school administrators and decision-makers.
What We Offer
Apollo After School is an equal opportunity employer committed to diversity and inclusion. We encourage applications from candidates of all backgrounds.
To apply, please submit your resume and a cover letter outlining your relevant business development experience in education.
As the Director of GraphAware Solutions EMEA, you will drive growth by leading strategic sales initiatives and partnerships within the national security and intelligence sectors across Europe.
The Obesity Therapeutic Area is seeking a Clinical Development Director to lead late phase studies in the maridebart cafraglutide (AMG 133) global development program for obesity and related metabolic diseases.
Leads translational medicine and pharmacology strategy across a clinical-stage immunology pipeline, advancing biomarker plans, mechanism-of-action research, and clinical and regulatory decisions for multiple sclerosis programs.
Leads global sales, technical, customer success, and partner enablement, building role-based programs, certifications, onboarding, and AI-powered learning that improve readiness and support platform growth.
Leads the creative department, team, capacity, and workflows while setting creative standards and delivering hands-on brand, campaign, web, pitch, and AI-enabled work.